-
KRD Maintenance Therapy Boosts Progression-Free Survival in Eligible Multiple Myeloma Patients Post-Transplant
Study Shows Carfilzomib Combo Boosts Survival in Newly Diagnosed Multiple Myeloma Patients Post-Transplant The phase 3 ATLAS trial (NCT02659293) conducted an unplanned interim analysis to evaluate the efficacy of maintenance therapy with carfilzomib, lenalidomide, and dexamethasone (KRd) compared to lenalidomide alone in patients with newly diagnosed multiple myeloma who underwent autologous stem cell transplant (ASCT)…
-
The Chemistry of Excellence: Saan Life Sciences’ Unwavering Commitment to Quality
Welcome to the Saan Life Sciences blog, where we take you behind the scenes of our commitment to excellence in chemical manufacturing. At Saan, quality is not just a standard; it’s a philosophy embedded in every aspect of our operations. Setting the Standard for Chemical Manufacturing Quality is the bedrock of Saan Life Sciences. From…
-
Saan Life Sciences: Navigating the Future with Innovation in Chemical Manufacturing
In the dynamic world of chemical manufacturing, staying ahead requires a constant commitment to innovation. At Saan Life Sciences, we don’t just keep up; we lead the way. Join us as we explore the innovative approaches that define our journey into the future. Smart Manufacturing for Tomorrow’s World In an era of Industry 4.0, we’re…
-
Innovation in Chemical Manufacturing: Saan Life Sciences’ Commitment to a Greener Future
At Saan Life Sciences, we’re not just manufacturers; we’re innovators dedicated to shaping a sustainable future. Our commitment to environmental responsibility is at the heart of everything we do. In our latest endeavor, we delve into the world of eco-friendly chemical manufacturing. Recognizing the global call for greener solutions, our research and development team has…
